drug

Quinidine Gluconate

MeSH C016713
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Otsuka Pharmaceutical Development & Commercialization, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women
NCT07305779Phase 1Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Otsuka Pharmaceutical Development & Commercialization, Inc.
company
trial
A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women
PHASE1
trial
indication
Schizophrenia
indication
Schizophrenia
indication